<SEC-DOCUMENT>0001104659-25-081891-index.html : 20250822
<SEC-HEADER>0001104659-25-081891.hdr.sgml : 20250822
<ACCEPTANCE-DATETIME>20250822161545
ACCESSION NUMBER:		0001104659-25-081891
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250820
FILED AS OF DATE:		20250822
DATE AS OF CHANGE:		20250822

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Basso Stephen
		CENTRAL INDEX KEY:			0001815707
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30319
		FILM NUMBER:		251246480

	MAIL ADDRESS:	
		STREET 1:		C/O INOZYME PHARMA, INC.
		STREET 2:		321 SUMMER STREET, SUITE 400
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviva, Inc.
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1350 OLD BAYSHORE HIGHWAY
		STREET 2:		SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
		BUSINESS PHONE:		6502389600

	MAIL ADDRESS:	
		STREET 1:		1350 OLD BAYSHORE HIGHWAY
		STREET 2:		SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THERAVANCE INC
		DATE OF NAME CHANGE:	20020207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2524111-2_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2524111-2_4seq1.html

Document 1 - RAW XML: tm2524111-2_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>